Matt Hewitt
Stock Analyst at Craig-Hallum
Total Price Targets
4
Stocks Covered
4
Sectors
Healthcare
Most Recent
Dec 17, 2024
Stocks Covered by Matt Hewitt
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CLOV | Clover Health Investments, Corp. | $6.00 | $2.71 | +121.0% | 1 | Dec 17, 2024 |
| BLFS | BioLife Solutions, Inc. | $30.00 | $21.30 | +40.8% | 1 | Aug 12, 2024 |
| LGND | Ligand Pharmaceuticals Incorporated | $140.00 | $229.62 | -39.0% | 1 | Jul 9, 2024 |
| TDOC | Teladoc Health, Inc. | $67.00 | $6.48 | +934.0% | 1 | Feb 23, 2022 |
Recent Activity
Frequently Asked Questions
Who is Matt Hewitt?
Matt Hewitt is a stock analyst at Craig-Hallum covering 4 stocks primarily in Healthcare. They have issued 4 price targets since Feb 23, 2022.
What stocks does Matt Hewitt cover?
Matt Hewitt currently covers 4 stocks, including CLOV, BLFS, LGND, TDOC.
What is Matt Hewitt's latest price target?
Matt Hewitt's most recent price target was $6.00 on CLOV (Clover Health Investments, Corp.), set on Dec 17, 2024.
What is Matt Hewitt's highest price target?
Matt Hewitt's highest issued price target is $140.00 on LGND, set on Jul 9, 2024.
More Analysts at Craig-Hallum
Coverage based on publicly published price targets. Not investment advice.